WENDY VOTTERO: Open Payments
NPI 1699141184 · GARY, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$485 in 19 payments from 8 companies in 2025. Trend: 2023 $368 · 2024 $603 · 2025 $485
Food & beverage: $485
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 5 | $103 |
| Otsuka America Pharmaceutical, Inc. | 4 | $100 |
| AKEBIA THERAPEUTICS INC | 1 | $97 |
| Fresenius USA Marketing, Inc. | 4 | $93 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Travere Therapeutics, Inc. | 1 | $25 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $19 |
| Novo Nordisk Inc | 1 | $17 |
Products named: IBSRELA, JYNARQUE, Vafseo, VELPHORO, FARXIGA, Ozempic.
Industry payments across IN — which companies pay providers there.
